Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Genpact Ltd (NYSE: G) closed the day trading at $30.69 down -3.37% from the previous closing price of $31.76. In other words, the price has decreased by -$3.37 from its previous closing price. On the day, 3.21 million shares were traded. G stock price reached its highest trading level at $31.9 during the session, while it also had its lowest trading level at $30.54.
Ratios:
For a better understanding of G, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.48 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.71. For the most recent quarter (mrq), Quick Ratio is recorded 1.44 and its Current Ratio is at 1.44. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on January 30, 2024, initiated with a Neutral rating and assigned the stock a target price of $40.
On December 15, 2023, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $38.
JP Morgan Downgraded its Neutral to Underweight on August 22, 2023, while the target price for the stock was maintained at $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 15 ’24 when Klunk Donald J sold 1,845 shares for $36.27 per share. The transaction valued at 66,910 led to the insider holds 6,922 shares of the business.
White Heather sold 11,450 shares of G for $412,200 on Jan 22 ’24. The SVP & Chief Legal Officer now owns 21,175 shares after completing the transaction at $36.00 per share. On Dec 04 ’23, another insider, Stein Kathryn Vanpelt, who serves as the Senior Vice President of the company, sold 57,336 shares for $34.85 each. As a result, the insider received 1,998,149 and left with 85,775 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, G now has a Market Capitalization of 5727367680 and an Enterprise Value of 6461607936. As of this moment, Genpact’s Price-to-Earnings (P/E) ratio for their current fiscal year is 8.97, and their Forward P/E ratio for the next fiscal year is 9.33. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.24 while its Price-to-Book (P/B) ratio in mrq is 2.45. Its current Enterprise Value per Revenue stands at 1.443 whereas that against EBITDA is 8.906.
Stock Price History:
Over the past 52 weeks, G has reached a high of $44.63, while it has fallen to a 52-week low of $29.41. The 50-Day Moving Average of the stock is -7.87%, while the 200-Day Moving Average is calculated to be -12.47%.
Shares Statistics:
Over the past 3-months, G traded about 1.60M shares per day on average, while over the past 10 days, G traded about 1522160 shares per day. A total of 179.49M shares are outstanding, with a floating share count of 178.34M. Insiders hold about 1.11% of the company’s shares, while institutions hold 89.35% stake in the company. Shares short for G as of 1713139200 were 5169376 with a Short Ratio of 3.23, compared to 1710460800 on 3371397. Therefore, it implies a Short% of Shares Outstanding of 5169376 and a Short% of Float of 3.7199999999999998.
Dividends & Splits
G’s forward annual dividend rate is 0.56, up from 0.55 a year ago. Against a Trailing Annual Dividend Yield of 0.01731738The stock’s 5-year Average Dividend Yield is 1.05.
Earnings Estimates
Current recommendations for the stock of the company come from 11.0 analysts. On average, analysts expect EPS of $0.68 for the current quarter, with a high estimate of $0.72 and a low estimate of $0.67, while EPS last year was $0.68. The consensus estimate for the next quarter is $0.73, with high estimates of $0.74 and low estimates of $0.71.
Analysts are recommending an EPS of between $3.06 and $2.94 for the fiscal current year, implying an average EPS of $3.01. EPS for the following year is $3.29, with 12.0 analysts recommending between $3.47 and $3.2.
Revenue Estimates
10 analysts predict $1.11B in revenue for the current quarter. It ranges from a high estimate of $1.11B to a low estimate of $1.09B. As of the current estimate, Genpact Ltd’s year-ago sales were $1.1BFor the next quarter, 10 analysts are estimating revenue of $1.13B. There is a high estimate of $1.13B for the next quarter, whereas the lowest estimate is $1.12B.
A total of 11 analysts have provided revenue estimates for G’s current fiscal year. The highest revenue estimate was $4.66B, while the lowest revenue estimate was $4.57B, resulting in an average revenue estimate of $4.59B. In the same quarter a year ago, actual revenue was $4.48BBased on 11 analysts’ estimates, the company’s revenue will be $4.88B in the next fiscal year. The high estimate is $5.05B and the low estimate is $4.81B.
